Catalog No.
YVV23406
Expression system
E. coli
Species
Influenza A virus (A/Hangzhou/1/2013(H7N9))
Protein length
[Gly21-Tyr151] & [Met1-Pro25]3
Predicted molecular weight
24.08 kDa
Nature
Recombinant
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P28307 & AGI60299.2
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Matrix protein 2, Proton channel protein M2, M, Major curlin subunit, csgA, b1042, JW1025
Note
For research use only.
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020., PMID:40008897
Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis and Transmission of Human Influenza A(H5N1) Clade 2.3.4.4b Virus in Ferret Model., PMID:40023783
Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity., PMID:40023796
Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice., PMID:40035774
Cross-species and mammal-to-mammal transmission of clade 2.3.4.4b highly pathogenic avian influenza A/H5N1 with PB2 adaptations., PMID:40044729
Neutralizing Antibody Response to Influenza A(H5N1) Virus in Dairy Farm Workers, Michigan, USA., PMID:40053378
One-pot synthesized three-way junction based multiple strand displacement amplification for sensitive assay of H5N1 DNA., PMID:40078160
Immune history shapes human antibody responses to H5N1 influenza viruses., PMID:40082696
Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines., PMID:40091614
Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case study., PMID:40099807
Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies., PMID:40101386
Highly Pathogenic Avian Influenza Virus Exposure and Infection in Free-Ranging Bobcats (Lynx rufus) in New York, USA., PMID:40103422
Unique immune and other responses of human nasal epithelial cells infected with H5N1 avian influenza virus compared to seasonal human influenza A and B viruses., PMID:40126073
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices., PMID:40128814
Cellular SLC35B4 promotes internalization during influenza A virus entry., PMID:40130891
Detection of antibodies against influenza A viruses in cattle., PMID:40130892
Exposure of Wild Mammals to Influenza A(H5N1) Virus, Alaska, USA, 2020-2023., PMID:40133065
Dose-Dependent Effect of DNA Vaccine pVAX-H5 Encoding a Modified Hemagglutinin of Influenza A (H5N8) and Its Cross-Reactivity Against A (H5N1) Influenza Viruses of Clade 2.3.4.4b., PMID:40143259
Fluorescent Microsphere Immunoassay for Isotype-Specific H5N1 Antibody Detection in Serum and Milk Samples From Dairy Cattle: A Tool for Epidemiological Surveillance., PMID:40145266
Cats as sentinels of mammal exposure to H5Nx avian influenza viruses: a seroprevalence study, France, December 2023 to January 2025., PMID:40156347
Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models., PMID:40169649
Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2., PMID:40171981
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens., PMID:40181968
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin., PMID:40192291
A paper-based loop-mediated isothermal amplification assay for highly pathogenic avian influenza., PMID:40204842
Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023., PMID:40205236
Safety and Immunogenicity of Poultry Vaccine for Protecting Critically Endangered Avian Species against Highly Pathogenic Avian Influenza Virus, United States., PMID:40233764
Dairy cows develop protective immunity against reinfection with bovine H5N1 influenza virus., PMID:40247094
Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578
Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data., PMID:40262547
Comparative Mutational Analysis and the Glycosylation Patterns of a Peruvian Isolated Avian Influenza A Virus H5N1: Exploring Possible Viral Spillover Events Within One Health Approach., PMID:40284894
Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype., PMID:40284987
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Pathogenic and Antigenic Analyses of H5N1 High Pathogenicity Avian Influenza Virus Isolated in the 2022/2023 Season From Poultry Farms in Izumi City, Japan., PMID:40302740
Severe Avian Influenza A H5N1 Clade 2.3.4.4b Virus Infection in a Human with Continuation of SARS-CoV-2 Viral RNAs., PMID:40303095
Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction., PMID:40315333
Intranasally administered whole virion inactivated vaccine against clade 2.3.4.4b H5N1 influenza virus with optimized antigen and increased cross-protection., PMID:40320528
Unique phenomenon of H5 highly pathogenic avian influenza virus in China: co-circulation of Clade 2.3.4.4b H5N1 and H5N6 results in diversity of H5 Virus., PMID:40326336
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Genetic diversity of A(H5N1) avian influenza viruses isolated from birds and seals in Russia in 2023., PMID:40369040
Pathogenicity and transmissibility of bovine-derived HPAI H5N1 B3.13 virus in pigs., PMID:40396285
Novel Minimal Absent Words Detected in Influenza A Virus., PMID:40431670
Phylogenetic Analysis and Spread of HPAI H5N1 in Middle Eastern Countries Based on Hemagglutinin and Neuraminidase Gene Sequences., PMID:40431745
Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus., PMID:40435634
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024., PMID:40439507
First contact: an interdisciplinary guide into decoding H5N1 influenza virus interactions with glycosaminoglycans in 3D respiratory cell models., PMID:40444153
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
Immediate PB2-E627K amino acid substitution after single infection of highly pathogenic avian influenza H5N1 clade 2.3.4.4b in mice., PMID:40474192
In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method., PMID:40522882
For research use only. Not for human or drug use.
